ArticleCells2021

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype.

Toomas Jagomäe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.